An international research group from the Medical University of Vienna reportedly found that a well-known rheumatoid arthritis medication containing the active agent adalimumab is also an effective treatment for non-infectious uveitis.
Researchers reportedly examined adult patients with active noninfectious intermediate uveitis, posterior uveitis, or panuveitis. Patients randomly received adalimumab or a matched placebo, and according to researchers the trial results found adalimumab was associated with a lower risk of uveitic flare or visual impairment. Researchers also stated this study shows for the first time that non-infectious uveitis can be successfully treated with a cortisol-free medication.
The results of the study were recently published in the New England Journal of Medicine.
Click here to read the full press release.
Source: Medical University of Vienna